LNA Santé Statistics

Total Valuation

LNA Santé has a market cap or net worth of EUR 238.25 million. The enterprise value is 1.05 billion.

Market Cap	238.25M
Enterprise Value	1.05B

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	Jul 8, 2024

Share Statistics

LNA Santé has 10.23 million shares outstanding. The number of shares has decreased by -1.29% in one year.

Current Share Class	n/a
Shares Outstanding	10.23M
Shares Change (YoY)	-1.29%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	13.86%
Float	6.75M

Valuation Ratios

The trailing PE ratio is 9.98 and the forward PE ratio is 9.31.

PE Ratio	9.98
Forward PE	9.31
PS Ratio	0.31
PB Ratio	0.78
P/TBV Ratio	n/a
P/FCF Ratio	2.18
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.14, with an EV/FCF ratio of 9.60.

EV / Earnings	43.94
EV / Sales	1.37
EV / EBITDA	7.14
EV / EBIT	16.09
EV / FCF	9.60

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 2.75.

Current Ratio	0.91
Quick Ratio	0.49
Debt / Equity	2.75
Debt / EBITDA	5.91
Debt / FCF	7.97
Interest Coverage	2.27

Financial Efficiency

Return on equity (ROE) is 8.08% and return on invested capital (ROIC) is 3.39%.

Return on Equity (ROE)	8.08%
Return on Assets (ROA)	2.65%
Return on Capital (ROIC)	3.39%
Revenue Per Employee	97,260
Profits Per Employee	3,043
Employee Count	9,037
Asset Turnover	0.49
Inventory Turnover	3.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.25% in the last 52 weeks. The beta is 0.81, so LNA Santé's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	+22.25%
50-Day Moving Average	24.03
200-Day Moving Average	23.64
Relative Strength Index (RSI)	45.89
Average Volume (20 Days)	3,581

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LNA Santé had revenue of EUR 762.03 million and earned 23.84 million in profits. Earnings per share was 2.34.

Revenue	762.03M
Gross Profit	248.34M
Operating Income	65.66M
Pretax Income	37.47M
Net Income	23.84M
EBITDA	87.98M
EBIT	65.66M
Earnings Per Share (EPS)	2.34

Full Income Statement

Balance Sheet

The company has 70.06 million in cash and 870.28 million in debt, giving a net cash position of -800.22 million or -78.26 per share.

Cash & Cash Equivalents	70.06M
Total Debt	870.28M
Net Cash	-800.22M
Net Cash Per Share	-78.26
Equity (Book Value)	316.16M
Book Value Per Share	30.03
Working Capital	-38.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 120.46 million and capital expenditures -11.30 million, giving a free cash flow of 109.16 million.

Operating Cash Flow	120.46M
Capital Expenditures	-11.30M
Free Cash Flow	109.16M
FCF Per Share	10.68

Full Cash Flow Statement

Margins

Gross margin is 32.59%, with operating and profit margins of 8.62% and 3.13%.

Gross Margin	32.59%
Operating Margin	8.62%
Pretax Margin	4.92%
Profit Margin	3.13%
EBITDA Margin	11.55%
EBIT Margin	8.62%
FCF Margin	14.32%

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 2.58%.

Dividend Per Share	0.60
Dividend Yield	2.58%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	2
Payout Ratio	21.45%
Buyback Yield	1.29%
Shareholder Yield	3.86%
Earnings Yield	10.02%
FCF Yield	45.82%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LNA Santé has an Altman Z-Score of 0.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.73
Piotroski F-Score	n/a